Introduction: Alpinia caerulea is a perennial herb which grows in coastal regions of Australia. All parts of this species are consumed as a bushfood. Furthermore, A. caerulea is taxonomically related to several plant species with well documented antimicrobial properties. Despite this, A. caerulea leaf solvent extractions have not previously been examined for antibacterial properties. Methods: The antimicrobial activity of A. caerulea leaf solvent extractions was investigated by disc diffusion and growth time course assays against a panel of pathogenic bacteria. The growth inhibitory activity was quantified by MIC determination. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: Methanolic and aqueous A. caerulea leaf extracts inhibited the growth of a range of gram positive and gram negative bacterial species. The methanolic extract was generally a more potent growth inhibitor than the aqueous extract. The methanolic and aqueous extracts were particularly potent inhibitors of S. marcenscens growth, with MIC values as low as 188 µg/mL for the methanolic extract. P. mirabilis (MICs of 785 and 976 µg/mL for the methanolic and aqueous extracts respectively) and K. pneumoniae growth (MICs of 1167 and 924 µg/mL for the methanolic and aqueous extracts respectively) were also particularly susceptible to the A. caerulea leaf extracts. The antibacterial activity of the methanolic and aqueous A. caerulea leaf extracts was further
INTRODUCTION
Alpinia caerulea (R.Br.) Benth. (family Zingiberaceae; synonym Hellenia caerulea R.Br.; commonly known as Australian native ginger and blue berry ginger) is a perennial herb which grows in the shaded understorey of rainforests and wet shlerophyll forests in eastern coastal regions of Australia, extending from Sydney to the tropical regions of far northern Queensland. 1 A. caerulea grows up to 2 m tall, with only the leaves growing above ground level (as with other Zingiberaceae spp., the stem grows below ground level). The sessile leaves ( Figure 1a (Figure 1d ). The flesh inside the fruit is white and contains a single black seed. The first Australians used A. caerulea as a nutritious, flavoursome snack. The fruit pulp was consumed directly and the seeds were discarded. Alternatively, the fruit can be dried and ground and used as a flavouring agent. Whilst the fruit is most often cited as a bushfood, all parts of the plant are edible and have been used by Australian Aborigines as well as early colonial settlers in their cuisine. The leaves can be dried, ground and used both as a spice and as an herbal infusion. Wrapping food in the leaves imparts a gingery flavour and was sometimes used in traditional cookery. The centres of the new shoots have a distinct gingery flavour and can be used fresh in cooking as a ginger substitute. The below ground parts (roots and stem) have a stronger, more earthy ginger flavour and are used sparingly in cooking. We were unable to find reports of the use of A. caerulea by Australian Aborigines as a traditional medicine. Instead, it appears to have been more valued as a culinary plant. However, the first Australians passed on traditional knowledge orally and there is a lack of written records from the early days of European colonisation which document the use of plants for therapeutic purposes. Therefore, much of the first Australian's traditional knowledge of medicinal plants has been lost. It is therefore possible that the first Australians may also have had therapeutic (as well as culinary) uses for A. caerulea. Notably, A. caerulea shares close taxonomic relationships with several other culinary plants from other regions of the world with well-established therapeutic properties. It is taxonomically related to Alpinia galangal (galangal), Zingiber officinale (common ginger), Curcuma longa (turmeric) and cardamom (Elettaria spp., Amomum spp.). All of these plants are members of family Zingiberaceae and all have well documented therapeutic properties. [2] [3] [4] [5] It is possible that A. caerulea may contain similar phytochemicals and have similar therapeutic properties. Several interesting phytochemical components have been identified in A. cearulea extracts. In particular, 2 diterpenoids were isolated from A. cearulea fruit and identified as zerumin A (Figure 1e ) and (E)-8(17), 12-labdadiene-15,16-dial (Figure 1f) . 6 That study focussed on the antiangiogenic activity of A. cearulea extracts and the isolated compounds and did not screen them for the ability to inhibit bacterial growth. Furthermore, we were unable to find any other studies examining the antibacterial properties of these compounds. A different study examined the phytochemistry and antibacterial properties of extracts prepared from the rhizome of the related species Alpinia pahangensis Ridley. 7 That study identified 2 different diterpenoids which were structurally similar to the A. cearulea fruit diterpenoids. Indeed, pahangensin B is a methylated form of zerumin A and pahangensin A is a dimeric form of pahangensin B. Interestingly that study tested pahangensin A and pahangensin B for antibacterial activity and reported potent growth inhibition. Indeed, pahangensin A was reported to have similar antibacterial potency as pure streptomycin and chloramphenicol against S. aureus and B. subtilis and substantially better potency than penicillin against B. cereus. Both A. pahangensis diterpenoids only inhibited gram positive bacterial growth and had no effect on gram negative bacteria. Despite these promising studies, examination of the antibacterial properties of A. cearulea extracts and isolated compounds is lacking. The current report was undertaken to screen A. cearulea leaf extracts for growth inhibitory properties against a panel of pathogenic bacteria.
MATERIALS AND METHODS

Plant collection and extraction
Alpinia cearulea (R.Br.) Benth. leaves were obtained from and identified by Philip Cameron, senior botanic officer, Mt Cootha Botanical Gardens, Brisbane, Australia. Leaf samples were dried in a Sunbeam food dehydrator and stored at -30 o C. Prior to use, the dried leaves was freshly ground to a coarse powder and 1 g quantities were weighed into separate tubes. A volume of 50 mL methanol, sterile deionised water, ethyl acetate, chloroform or hexane was added to individual tubes and extracted for 24 h at 4 o C with gentle shaking. All solvents were obtained from Ajax, Australia and were AR grade. The extracts was filtered through filter paper (Whatman No. 54) under vacuum, followed by drying by rotary evaporation in an Eppendorf concentrator 5301. The resultant pellets were dissolved in 10 mL sterile deionised water (containing 1% DMSO). The extracts were passed through 0.22 µm filter (Sarstedt) and stored at 4 o C until use.
Qualitative phytochemical studies
Phytochemical analysis of the A. cearulea leaf extracts for the presence of saponins, phenolic compounds, flavonoids, phytosteroids, triterpenoids, cardiac glycosides, anthraquinones, tannins and alkaloids was conducted by previously described assays. [8] [9] [10] Antibacterial screening Test microorganisms 
Evaluation of antimicrobial activity
Antimicrobial activity of all plant extracts was determined using a modified disc diffusion assay. [11] [12] [13] Briefly, 100 µL of each bacterial culture was grown in 10 mL of fresh nutrient broth until they reached a count of ~10 8 cells/mL. A volume of 100 µL of the bacterial suspension was spread onto nutrient agar plates and extracts were tested for antibacterial activity using 5 mm sterilised filter paper discs. Discs were infused with 10 µL of the plant extracts, allowed to dry and placed onto the inoculated plates. The plates were allowed to stand at 4°C for 2 h before incubation at 30°C for 24 h. The diameters of the inhibition zones were measured to the closest whole millimetre. Each assay was performed in at least triplicate. Mean values (± SEM) are reported in this study. Standard discs of ampicillin (10 µg) were obtained from Oxoid, Australia and were used as positive controls to compare antibacterial activity. Filter discs infused with 10 µL of distilled water were used as a negative control.
Minimum inhibitory concentration (MIC) determination
The minimum inhibitory concentration (MIC) of each extract against susceptible bacteria was determined as previously described. [14] [15] Briefly, the A. cearulea leaf extracts were diluted in deionised water and tested across a range of concentrations. Discs were infused with 10 µL of the test dilutions, allowed to dry and placed onto inoculated plates. The assay was completed as outlined above and graphs of the zone of inhibition versus concentration were plotted for each extract. Linear regression was used to determine the MIC values of each extract.
Bacterial growth time course assay
Bacterial growth time course studies were performed as previously described. 16 Briefly, 3 mL of Proteus mirabilis (ATCC21721) and S. marcenscens in nutrient broth were individually added to 27 mL nutrient broth containing 3 mL of 10 mg/mL methanolic or aqueous plant extract to give a final concentration of 1000 µg/mL in the assay. The tubes were incubated at 30 o C with gentle shaking. The optical density was measured hourly at 550 nm for a 6 h incubation period. Control tubes were incubated under the same conditions but without the extract. All assays were performed in triplicate.
Toxicity screening Reference toxin for toxicity screening
Potassium dichromate (K 2 Cr 2 O 7 ) (AR grade, Chem-Supply, Australia) was prepared as a 4 mg/mL solution in distilled water and was serially diluted in artificial seawater for use in the Artemia franciscana nauplii bioassay.
Artemia franciscana nauplii toxicity screening
Toxicity was tested using an adapted Artemia franciscana nauplii lethality assay. [17] [18] [19] Briefly, 400 µL of seawater containing approximately 58 (mean 57.6, n = 75, SD 11.6) A. franciscana nauplii were added to wells of a 48 well plate and immediately used for bioassay. A volume of 400 µL of diluted plant extracts or the reference toxin were transferred to the wells and incubated at 25 ± 1 o C under artificial light (1000 Lux). A 400 µL seawater negative control was run in triplicate for each plate. All treatments were performed in at least triplicate. The wells were checked at regular intervals and the number of dead counted. The nauplii were considered dead if no movement of the appendages was detected within 10 sec. After 24 h, all nauplii were sacrificed and counted to determine the total % mortality per well. The LC 50 with 95% confidence limits for each treatment was determined using probit analysis. Statistical analysis Data are expressed as the mean ± SEM of at least three independent experiments. One way ANOVA was used to calculate statistical significance between control and treated groups with a P value < 0.01 considered to be statistically significant.
RESULTS
Liquid extraction yields and qualitative phytochemical screening
Extraction of 1 g of dried and powdered A. cearulea leaf with solvents of varying polarity yielded dried extracts ranging from 54 mg (hexane extract) to 158 mg (methanol extract) ( Table 1 ). The aqueous (126 mg) and chloroform extracts (117 mg) also yielded relatively high levels of extracted materials. The dried extracts were resuspended in 10 mL of deionised water (containing 1% DMSO), resulting in the extract concentrations shown in Table 1 . Qualitative phytochemical studies showed that the higher polarity methanol and water solvents extracted the greatest diversity and highest levels of phytochemicals. Both contained high levels of phenolics and flavonoids and low-moderate levels of saponins, triterpenoids and tannins. The ethyl acetate extract contained similar phytochemical classes, albeit generally at lower levels. Interestingly, despite extracting relatively large amounts of material, the chloroform and hexane extracts were devoid of all classes of phytochemicals screened. Due to their nonpolar nature, these extracts would be expected to contain high levels of lipids, hydrocarbons etc. As our qualitative phytochemical studies did not screen for these compounds, they were not detected and other techniques are required to further examine the nature of these nonpolar components.
Antimicrobial activity
To determine the growth inhibitory activity of the A. cearulea leaf extracts against the panel of pathogenic bacteria, aliquots (10 µL) of each extract were screened in the disc diffusion assay. The methanolic and aqueous A. cearulea leaf extracts inhibited 3 of the 10 (30 %) gram negative bacterial species screened in this study (Figure 2) . The methanolic A. cearulea leaf extract was generally a more potent growth inhibitor than the aqueous extract against most bacterial species (as assessed by the sizes of the zones of inhibition). The inhibition of S. marcenscens growth inhibition was particularly noteworthy, with the methanolic and aqueous extracts producing 10.0 ± 1.0 and 8.6 ± 0.6 mm respectively. This inhibition was particularly noteworthy compared to the inhibition by the ampicillin control (10 µg: inhibition zones of 6.6 ± 0.3 mm). P. mirabilis (8.3 ± 0.3 mm and 7.9 ± 0.6 mm for the methanolic and aqueous extracts respectively) and K. pneumoniae growth (7.3 ± 0.3 mm and 7.5 ± 0.5 mm for the methanolic and aqueous extracts respectively) were also susceptible to inhibition by the A. cearulea leaf extracts. The ethyl acetate extract also inhibited the growth of the same bacteria, albeit generally with substantially smaller inhibition zones than were recorded for methanolic and aqueous extracts. The chloroform and hexane extracts were generally devoid of growth inhibitory activity. Gram positive bacteria were also susceptible to the A. cearulea leaf extracts (Figure 3 ). Indeed, a higher proportion of the gram positive bacteria screened were susceptible compared to the gram negative bacteria. Of the 4 gram positive bacterial strains tested, 3 (75 %) were inhibited by both the methanolic and aqueous A. cearulea leaf extracts. With the exception of S. pyogenes, all of the susceptible gram positive bacteria were also inhibited by the ethyl acetate A. cearulea leaf extract. The chloroform and hexane extracts were completely devoid of bacterial growth inhibitory activity against all gram positive bacterial species. The antimicrobial efficacy was further quantified by determining the MIC values for each extract against the microbial species which were determined to be susceptible. The methanolic and aqueous A. cearulea leaf extracts were potent growth inhibitors of several bacterial species (as judged by MIC; Table 2 ). S. marcenscens was the most susceptible bacteria to the A. cearulea leaf extracts, with an MIC value of 188 µg/mL (<2 µg infused into the disc) recorded for the methanolic extract. The aqueous and ethyl acetate extracts were also potent S. marcenscens growth inhibitors, with MIC values of 405 and 846 µg/mL respectively. P. mirabilis and K. pneumoniae were also highly susceptible to the methanolic and aqueous A. cearulea leaf extracts, generally with MIC values <1000 µg/mL. As P. mirabilis infection is a common cause of 
+++ indicates a large response; ++ indicates a moderate response; + indicates a minor response; -indicates no response in the assay. 
Gram negative bacteria
A. faecalis urinary tract infections and has also been identified as a trigger of rheumatoid arthritis, 20-21 the aqueous and methanolic A. cearulea leaf extracts have potential for the prevention of these diseases in genetically susceptible individuals. Similarly, K. pneumoniae is a microbial trigger of ankylosing spondylitis. [22] [23] indicating the potential of the aqueous and methanolic A. cearulea leaf extracts in the prevention and treatment of this disease. The aqueous and methanolic A. cearulea leaf extracts also displayed moderate growth inhibitory activity towards the gram positive bacteria B. cereus, S. aureus and S. pyogenes, with MIC values in the 1000-2300 µg/mL range. Moderate to low growth inhibition (or no inhibition) was noted for all other extract/bacterium combinations.
Bacterial growth time course assay
The antibacterial activity of the A. cearulea leaf extracts was further investigated in the P. mirabilis and S. marcenscens by bacterial growth time course assays in the presence and absence of the A. cearulea extracts. Only the effect of the methanolic and aqueous extracts on the bacterial growth time course were evaluated as these extracts were the most potent bacterial growth inhibitors (as judged by MIC). Furthermore, the time course studies only examined the effect of the extracts on the P. mirabilis and S. marcescens as these were the most susceptible bacterial species. The starting concentration of the extract used in these assays was 1000 µg/mL. The methanolic and aqueous A. cearulea leaf extracts significantly inhibited P. mirabilis (Figure 4a ) and S. marcescens growth (Figure 4b ) within 1 h, indicating a rapid antimicrobial action. Whilst P. mirabilis growth was inhibited for 4-5 h of the time course, the bacteria were able to overcome this inhibition by 6h, with the recorded turbidity not significantly different to that of the untreated control. This indicates that the growth inhibition of these bacteria was bacteriostatic for the methanolic A. cearulea leaf extract at the concentrations tested. A similar inhibitory time course was evident for S. marcescens growth in the presence of aqueous A. cearulea extract. S. marcescens growth was inhibited for 4-5 h of the time course, although the bacterium overcame the inhibition by 6 h. In contrast, inhibition of S. marcescens growth by the methanolic A. cearulea leaf extract was substantially more profound, with growth still significantly inhibited by the end of the 6 h time course study. This may indicate that the methanolic A. cearulea leaf extract has bactericidal activity against S. marcescens at the dose tested. Indeed, the turbidity at 6 h was not greatly increased from the starting turbidity.
Quantification of toxicity
The toxicity of the A. cearulea leaf extracts was initially tested in the Artemia franciscana nauplii bioassay at a concentration of 2000 µg/mL ( Figure 5 ). All extracts induced low levels of mortality at 24 h, similar to the % mortality seen for the seawater control. By 48 h, the aqueous and methanolic extracts had begun to induce mortality significantly higher than that in the untreated control. However, the level of mortality was still substantially < 50 % toxicity at 48 h for all extracts. Thus, all of the A. cearulea leaf extracts were deemed to be nontoxic. Extracts with an LC 50 >1000 µg/mL towards Artemia nauplii have previously been defined as being nontoxic. 19 In contrast, the potassium dichromate positive control induced mortality within 4 h (results not shown), with 100 % mortality induction seen by 24 h.
DISCUSSION
Pharmacognostic and natural product remedies are becoming increasingly sought after in the treatment and prevention of disease due to the failure of current drug regimens to effectively treat many diseases. This study reports on the growth inhibitory properties of A. cearulea leaf extracts against a panel of pathogenic bacteria and on their toxicity. Both gram positive and gram negative bacteria were susceptible to the S. formosa leaf extracts, although the gram positive bacteria had greater susceptibility (as judged by the number of bacteria inhibited). Indeed, the methanolic and aqueous extracts each inhibited 75 % of the gram positive bacterial species screened, compared to 30 % of the gram negative bacteria. This is consistent with many previous studies with other plant species which report a greater susceptibility of gram positive bacteria towards solvent extracts for South American, 24 African 25 and Australian. [26] [27] [28] plant extracts. Our study examined the ability of A. cearulea leaf extracts to inhibit the growth of a panel of medicinally important bacterial pathogens. The methanolic and aqueous extracts were identified as being particularly potent inhibitors of S. marcenscens growth, with MIC values of 188 and 405 µg/mL respectively. As S. marcenscens is a common cause of hospitalacquired infections, as well as urinary tract infections and wound infections, 22 A. cearulea leaf extracts may provide useful leads in the treatment of these diseases. The methanolic and aqueous extracts were also potent inhibitors of P. mirabilis growth, with MIC values of 785 and 976 µg/mL respectively. As P. mirabilis can trigger rheumatoid arthritis in genetically susceptible individuals, [20] [21] these extracts have potential for the development of rheumatoid arthritis preventative therapies. The methanolic and aqueous extracts also had moderate to good K. pneumoniae growth inhibitory properties, with MIC values of 1167 and 924 µg/mL respectively. As K. pneumoniae can trigger ankylosing spondylitis in genetically susceptible individuals, [22] [23] these extracts may also be useful in the prevention of that disease. The methanolic and aqueous A. cearulea leaf extracts also were moderate inhibitors of several other bacterial pathogens. Both the aqueous and methanolic A. cearulea leaf extracts were good inhibitors of B. cereus, S. aureus and S. pyogenes growth, with MIC values generally 1000-2300 µg/mL. As these bacteria have been implicated in a number of gastrointestinal and skin diseases, the aqueous and methanolic A. cearulea leaf extracts also may have applications in the treatment of these diseases. Whilst a detailed investigation of the phytochemistry of the A. cearulea leaf extracts was beyond the scope of our study, qualitative screening was used to determine the classes of compounds present. Several commonalities were noted: the most potent aqueous and methanolic extracts all contained relatively high levels of phenolics and flavonoids. Many studies have reported potent antibacterial activities for a wide variety of polyphenolic compounds, including many flavonoids. 29 Bioactivity driven isolation of active components is required to further identify the bioactive components and to evaluate the mechanism of bacterial growth inhibition. It is likely that other phytochemical classes may also contribute to the growth inhibitory properties of these extracts. Our qualitative phytochemical screening studies indicated that tannins were present in the A. cearulea leaf extracts in low to moderate levels. Many studies have reported potent growth inhibitory activities for a number of tannin compounds. Gallotannins have been reported to inhibit the growth of a broad spectrum of bacterial species 30 through a variety of mechanisms including binding cell surface molecules including lipotoichoic acid and proline-rich cell surface proteins [31] [32] and by inhibiting glucosyltransferase enzymes. 33 Elligitannins are also highly potent inhibitors of bacterial growth, with MIC values as low as 62.5 µg/mL. 30, 32 Ellagitannins have also been reported to function via several antibiotic mechanisms including interaction with cytoplasmic oxidoreductases and by disrupting bacterial cell walls. 31, 33 Thus, it is likely that A. cearulea leaf tannins may contribute to the inhibition of bacterial growth reported in our study. Triterpenoids were also detected in low to moderate levels in the inhibitory extracts. Many terpenoids have very good antibacterial activity 30 and it is therefore likely that these compounds may also contribute to the growth inhibitory properties reported here. Our findings also demonstrate that all of the A. cearulea leaf extracts were nontoxic towards Artemia franciscana nauplii, with 24 h LC 50 values substantially > 1000 µg/mL. Extracts with LC 50 values > 1000 µg/mL towards Artemia nauplii are defined as being nontoxic. 19 Whilst our preliminary toxicity studies indicate that these extracts may be safe for therapeutic use, studies using human cell lines are required to further evaluate the safety of these extracts. Whilst these studies have demonstrated the potential of the A. cearulea leaf extracts in the development of future antibiotic chemotherapeutics for the prevention and treatment of urinary tract infections, autoimmune diseases (particularly rheumatoid arthritis and ankylosing spondylitis) and some gastrointestinal and skin diseases, more work is required to isolate the inhibitory components and determine the mechanism of inhibition.
CONCLUSION
The results of this study demonstrate the potential of the A. cearulea leaf extracts as inhibitors of pathogenic bacteria growth. Furthermore, their lack of toxicity indicates than they are safe for internal as well as topical treatments. Further studies aimed at the purification and identification of bioactive components are needed to examine the mechanisms of action of these agents.
